CPT code 95065 denotes the technical component of nasal mucous membrane allergy testing, a targeted diagnostic procedure that assesses local allergic reactions in the nasal lining. This code is relevant nationally because nasal allergy testing informs diagnosis and management for patients with rhinitis, allergic symptoms, or suspected localized allergic disease, and it impacts billing allocations between technical and professional service components. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what the code represents, typical sites of service, and common billing modifiers; national reimbursement context and payer coverage patterns where available; and clinical context explaining when nasal mucosal testing is used versus other allergy-testing modalities. The publication provides benchmarks and policy-oriented notes to help billing managers, clinicians, and compliance officers understand coding practice and documentation expectations tied to the technical component of nasal mucous membrane testing. Data not provided in the input (such as associated taxonomies, specific ICD-10 pairings, and payer-specific rates) are noted as unavailable.